Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.

Publication ,  Journal Article
Langer, A; Minkowitz, J; Dorian, P; Casella, L; Harris, L; Morgan, CD; Armstrong, PW
Published in: J Am Coll Cardiol
November 15, 1992

OBJECTIVES: We performed Holter monitoring on days 4 and 7 after acute myocardial infarction in 109 patients to assess whether ST segment shift would identify those with more severe coronary artery disease, left ventricular dysfunction and unfavorable prognosis. BACKGROUND: Silent myocardial ischemia is a frequent and prognostically significant event after acute myocardial infarction. However, the specific pathophysiologic mechanisms and the impact of thrombolytic therapy are uncertain. METHODS: In addition to Holter monitoring, patients underwent exercise testing, radionuclide angiography on days 1 and 9 and quantitative coronary angiography on day 9. RESULTS: Thirty-five patients (32%) had ST segment depression and had similar recombinant tissue-type plasminogen activator (rt-PA) treatment assignment and a reduced cross-sectional area of the infarct-related artery (0.59 +/- 0.57 vs. 1.04 +/- 1.26 mm2, p < 0.05). Global left ventricular function improved from day 1 to day 9 in patients without (4% +/- 11%, p < 0.001) but not in those with (0% +/- 7%) ST segment depression. In-hospital event rates were similar; however, follow-up 18 +/- 11 months after hospital discharge revealed a greater frequency of death and recurrent myocardial infarction in patients with compared with those without ST segment depression (27% vs. 6%, p = 0.03). CONCLUSIONS: After acute myocardial infarction, approximately one third of patients have ST segment depression on Holter monitoring, independent of the use of thrombolytic therapy. The unfavorable prognosis observed in these patients may be related to greater lumen obstruction in the infarct-related artery and lack of improvement in left ventricular function.

Duke Scholars

Published In

J Am Coll Cardiol

DOI

ISSN

0735-1097

Publication Date

November 15, 1992

Volume

20

Issue

6

Start / End Page

1313 / 1317

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Recurrence
  • Recombinant Proteins
  • Prognosis
  • Myocardial Infarction
  • Humans
  • Follow-Up Studies
  • Exercise Test
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Langer, A., Minkowitz, J., Dorian, P., Casella, L., Harris, L., Morgan, C. D., & Armstrong, P. W. (1992). Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. J Am Coll Cardiol, 20(6), 1313–1317. https://doi.org/10.1016/0735-1097(92)90242-f
Langer, A., J. Minkowitz, P. Dorian, L. Casella, L. Harris, C. D. Morgan, and P. W. Armstrong. “Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.J Am Coll Cardiol 20, no. 6 (November 15, 1992): 1313–17. https://doi.org/10.1016/0735-1097(92)90242-f.
Langer A, Minkowitz J, Dorian P, Casella L, Harris L, Morgan CD, et al. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. J Am Coll Cardiol. 1992 Nov 15;20(6):1313–7.
Langer, A., et al. “Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.J Am Coll Cardiol, vol. 20, no. 6, Nov. 1992, pp. 1313–17. Pubmed, doi:10.1016/0735-1097(92)90242-f.
Langer A, Minkowitz J, Dorian P, Casella L, Harris L, Morgan CD, Armstrong PW. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. J Am Coll Cardiol. 1992 Nov 15;20(6):1313–1317.
Journal cover image

Published In

J Am Coll Cardiol

DOI

ISSN

0735-1097

Publication Date

November 15, 1992

Volume

20

Issue

6

Start / End Page

1313 / 1317

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Recurrence
  • Recombinant Proteins
  • Prognosis
  • Myocardial Infarction
  • Humans
  • Follow-Up Studies
  • Exercise Test